Dr. Phong Thanh Dargon, MD

Dr. Dargon practices at Seven Oaks Surgery Center LLC - HOPD in San Bernardino, California.

Dr. Dargon's NPI, 1679733927, was assigned on June 11, 2008. Dr. Dargon graduated from UMass Chan Medical School in 2008. Dr. Dargon's California license number on file is A128212.

Dr. Dargon's primary practice is Seven Oaks Surgery Center LLC - HOPD, at 401 E Highland Ave, San Bernardino, CA 92404.

Dr. Dargon's primary practice is Seven Oaks Surgery Center LLC - HOPD in San Bernardino, California. Dr. Dargon is also affiliated with Dignity Health - St. Bernardine Medical Center. The medical group on file is Western Bariatric AMC. Dmand AI also links Dr. Dargon to 1 more hospital, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dargon practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Dargon's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Dargon's licenses on file in 3 states: California, Massachusetts and Oregon.

Dmand AI lists blood vessel access for dialysis, chronic skin ulcer, leg revascularization and peripheral vascular disease among the conditions Dr. Dargon treats.

CMS data shows 1,323 Medicare services from Dr. Dargon across 20 procedure codes in 2024, for 321 Medicare patients. Medicare paid $92,213 for them.

CMS counts 321 Medicare patients who saw Dr. Dargon in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 5.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dargon's median patient age at 62, with 44% women.

In 2024, Dr. Dargon wrote 56 Medicare Part D claims for 39 patients. 98% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $654 in total drug cost. In 2023, CMS named 159 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dargon for performance year 2024, reported individually. Dr. Dargon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of leg revascularization (restoring blood flow) by Dr. Dargon, more than 77% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Dargon, published from 2009 to 2014. 2013 was the busiest year, with 5. The most frequent topics are Aortic Aneurysm, Abdominal, Atherosclerosis and Chi-Square Distribution. Dr. Dargon has published most often in J Vasc Surg. Dr. Dargon's most frequent co-authors are Gregory Louis Moneta, MD, Amir Farzin Azarbal, MD and John Francis Eidt, MD.

CMS Open Payments shows 83 general payments to Dr. Dargon from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 61% of the total. TissueTech, Inc. paid the most, $1,450.

Dr. Dargon graduated from UMass Chan Medical School in 2008.

Dr. Dargon is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Aetna and LA Care. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.